Author Information
Robert J. Hogan is a distinguished researcher in the field of Infectious Diseases, currently affiliated with the Department of Infectious Diseases at the College of Veterinary Medicine, University of Georgia. His work primarily focuses on the development of novel therapeutics and vaccines against viral pathogens, including SARS-CoV-2 and influenza viruses. Through his research, he significantly contributes to understanding and combating viral infections, reflecting his standing in the scientific community.Research Contributions
Robert J. Hogan's research portfolio includes groundbreaking studies on antiviral therapeutics and the immune response to infectious diseases. His notable work involves the development and testing of host-targeted antiviral small molecules and the use of mRNA-encoded Cas13a for treating influenza and SARS-CoV-2. Additionally, he has explored the virulence factors of bacterial pathogens such as Burkholderia mallei, contributing to the broader field of infectious disease research. His research often emphasizes innovative approaches to inhibit viral replication and enhance host defense mechanisms.Aliases
Throughout his academic career, Robert J. Hogan has been published under various aliases, including R J Hogan, Robert Hogan, R. J. Hogan, Robert Jeff Hogan, R. Jeffrey Hogan, and Robert J Hogan. These variations often appear in different publications and databases, reflecting the common practice of using initials or name variations in academic publishing.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
4981 |
| H-Index |
28 |
| Total Paper Count |
77 |
